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Abstract The results on the multicomponent reaction between cyclic
Ǵ-keto esters, enals, and simple primary aliphatic amines are reported.
In thermal conditions in the presence of 4 Å molecular sieves, two
different families of heterocyclic products (aminobicyc-
lo[3.3.1]nonanones or cycloalka[b]piperidines) were obtained depend-
ing on the presence of a substituent in the ǳ-position of the aldehyde.
Moreover, preliminary results on the possibility to obtain these two bi-
cyclic cores from the very same starting materials by introducing or-
ganocatalysts with different activation modes in the reaction are pre-
sented.
Key words 1,3-dicarbonyls, heterocycles, Michael addition, multi-
component reaction, organocatalysis
Heteroatom-containing bridged and fused polycycles
are ubiquitous motives that are present both in natural
products and bioactive compounds, and new methods to
synthesize them are continuously being invented. One par-
ticularly efficient strategy is the use of domino multicom-
ponent reactions that consist in the chemoselective assem-
bly of at least three organic molecules to afford structurally
complex architectures.1,2 For more than ten years, our
group has been involved in the development of new multi-
component reactions that make use of the Michael addition
of 1,3-dicarbonyl compounds to trigger the formation of
valuable products, including a large variety of heterocy-
cles.3 In this context, we studied the combination of ethyl 1-
benzyl-4-oxopiperidine-3-carboxylate (1), acrolein, and
primary amines in the presence of 4 Å molecular sieves
(MS) in refluxing toluene and observed a chemodivergent
reaction, depending on the substitution of the amine
(Scheme 1, previous strategy):4 ǳ-branched primary
amines favored the formation of bridged aminoazabicyc-
lo[3.3.1]nonanones 2, whereas linear ones afforded hexahy-
dro-1,5-naphthyridines 3. The former family of products
presumably arises from a Michael addition-Mannich reac-
tion sequence, while the latter one was formed via a
Michael addition followed by double enamine formation by
tautomerization. We assumed that these reactions are re-
versible and that the relative stability of the products de-
pending on their substitution patterns could account for
the observed selectivity.
When reinvestigating the scope of this reaction regard-
ing carbocyclic Ǵ-keto esters and enals, it was realized that
the structure of the latter substrate could also guide the
chemoselectivity of the transformation. Herein, we wish to
present our results on the substrate chemo-controlled
Michael addition-initiated three-component synthesis of
functionalized original aminobicyclo[3.2.1]octan-8-ones
45,6 and cycloalka[b]piperidines 5 (Scheme 1, new strategy),
by studying the scope and limitations of both these three-
component reactions.
Moreover, in line with our recent success in carrying out
organocatalytic multicomponent syntheses of 2,6-diazabi-
cyclo[2.2.2]octanones and pyrrolopiperazines,7–9 attempts
to carry out the two new transformations in the presence of
an organocatalyst will be discussed. Even though enanti-
oselectivities remain low to moderate, our preliminary re-
sults highlight the intriguing possibility to obtain either
one or the other family of products from the same starting
materials depending on the selected organocatalyst.10
Three-Component Synthesis of Aminobicyc-
lo[3.2.1]octan-8-ones
The investigations were started by exposing ethyl 2-
oxocyclopentanecarboxylate (6a) to acrolein and primary
amines under our standard conditions: 4 Å MS in refluxing
toluene (Scheme 2). As expected from the results of our
seminal study,4 ǳ-branched primary amines such as isopro-
SYNTHESIS0 0 3 9 - 7 8 8 1 1 4 3 7 - 2 1 0 X
© Georg Thieme Verlag  Stuttgart · New York
2015, 47, 2188–2198
special topic
2189
© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2015, 47, 2188–2198
H. Du et al. Special TopicSyn thesis
pylamine (7a), cyclohexylamine (7b), or tert-butylamine
(7c) exclusively furnished bicyclic products 4a–c with
yields higher than 70% and modest diastereoselectivities.
More surprisingly, the use of a variety of linear primary
amines 7d–h also resulted in the formation of the bicyclic
products 4d–h with the same efficiency. Different syntheti-
cally interesting motives such as allyl groups and (hete-
ro)aromatics on the amine had no influence on the out-
come of the reaction.
Among the three stereogenic centers of the bicyclic
products 4a–h, the relative configuration of the two bridge-
head ones being fixed, only the determination of the rela-
tive configuration of the stereogenic center that bears the
amino group was required. After complete assignment of
the signals on the 1H and 13C NMR spectra of product 4d,
thanks to 2D NMR studies, we could notice that the hydro-
gen atom located on this position appears at 3.03 ppm and
possesses one 3Jax–ax coupling constant of 11.4 Hz, indicating
that the amino group is located on equatorial position (Fig-
ure 1). This observation is in accordance with our work on
the corresponding bicyclic structures bearing an alcohol in-
stead of the amine function.11
Figure 1  Assignment of the relative configurations in the aminobicyc-
lo[3.2.1]octan-8-one 4d
Three-Component Synthesis of Cycloalka[b]piperi-
dines
When replacing acrolein by an ǳ-substituted enal, such
as methacrolein (8a), a change in the chemoselectivity of
the reaction was observed (Scheme 3).
After the initial Michael addition, presumably because
of the additional steric hindrance brought by the ǳ-substit-
uent, the reaction did not deliver the bridged bicyclic prod-
ucts, but rather proceeded towards the formation of diene-
amines by addition of the nitrogen atom to the two carbon-
yl groups of the aldehyde and the ketone, respectively,
followed by dehydration. Because of the low stability of
these dieneamines, they were directly reduced by treat-
ment with NaBH4, in a THF–AcOH–MeOH mixture to fur-
nish the perhydrocycloalka[b]pyridines 5a–i, with moder-
ate to high diastereoselectivities. Pleasingly, a diversity of
linear aliphatic primary amines participated in this reac-
tion with high efficiency to deliver the product 5a–e in high
yields. On the contrary, ǳ-branched primary amines were
not suitable substrates in this reaction. Moreover, in addi-
tion to methacrolein, enals bearing ethyl or benzyl groups
in the ǳ-position were also suitable substrates, even though
products 5f and 5g were isolated in slightly reduced yields.
To finish with the scope of the study, we could also show
that a 6-membered cyclic Ǵ-keto ester was also able to effi-
ciently deliver the perhydroquinolines 5h and 5i.
Once again, the products obtained in this second multi-
component reaction possess three stereogenic centers, the
relative configuration of which was determined by analyz-
ing the coupling constants in 1H NMR spectra as shown for
compounds 5b and 5h, respectively (Figure 2).
Scheme 1  Chemodivergent three-component reactions: previous and 
new strategies
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Figure 2  Assignment of the relative configurations of cycloalka[b]pi-
peridines 5b,h
Both for the 5,6- and 6,6-bicyclic systems, the proton on
the carbon atom bearing the methyl group exhibits no char-
acteristic 3Jax–ax coupling constant, indicating that it is locat-
ed in equatorial position. As a consequence, the alkyl group
on the heterocycle is set in axial position. On the opposite,
the proton at the ring junction is placed in axial position
and so is the ester group, indicating the rings are fused with
a trans junction.
Proposed Mechanism: Origin of the Chemoselectivity
At first, it should be noted that, even though many of
the steps involved in these two reaction pathways are likely
to be reversible, the two products do not interconvert as
their reexposure to the reaction conditions did not lead to
any evolution. Based on the previous work in this field,4 we
propose that the reaction is initiated by the Michael addi-
tion of the 1,3-keto ester to the enal, followed by imine for-
mation on the resulting aliphatic aldehyde, to deliver the
key intermediate A (Scheme 4). When R2 = H, after keto–
enol tautomerism to form B, the imine can undergo an in-
tramolecular Mannich reaction to deliver the bridged bicy-
clic product 4. On the contrary, we can surmise that the
added steric hindrance provided by the substituent R2
when it is different from an hydrogen atom, is responsible
for the shift in chemoselectivity, by preventing the Mannich
reaction or making it reversible under the reaction condi-
tions. In a complementary manner, the R2 substituent will
also favor the imine–enamine tautomerism towards inter-
mediate C, by increasing the stability of the more substitut-
Scheme 2  Three-component synthesis of oxobicyclo[3.2.1]octanes
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ed enamine. Consequently, the cyclization can occur this
time by nucleophilic addition of the nitrogen atom to the
ketone. Subsequent dehydration furnishes D, which is re-
duced to allow isolating the final product 5. The higher sta-
bility of the more substituted dieneamine D when R2 is an
alkyl chain can be another possible explanation for the che-
moselectivity.
Organocatalyst-Controlled Chemodivergent Three-
Component Reaction: Preliminary Results
In the recent years, organocatalysis has emerged as a
very efficient tool to perform enantioselective multicompo-
nent reactions.9 For this reason, our attention was turned
towards the possibility to combine a cyclic Ǵ-keto ester,
methacrolein, and allylamine in the presence of an organo-
catalyst to try to form enantioenriched polyheterocyclic
products (Table 1).
As soon as the screening was started, it became clear
that either family of product could be exclusively obtained
in a highly chemoselective manner from the same starting
materials depending on whether covalent12 or noncova-
lent13 organocatalysts were used. Proline-derived second-
ary amine I14 did not allow the formation of any of the two
products (Table 1, entry 1). Assuming that a reason for this
lack of reactivity was the high steric hindrance of methac-
rolein (8a), we turned our attention towards primary
amines. Even though cinchona-alkaloid derived catalyst II15
was inefficient (entry 2), bifunctional thiourea-primary
amine III16 enabled the chemoselective formation of the
fused bicyclic product (entry 3). After reduction, perhydro-
cyclopenta[b]pyridine 5b was isolated in 65% yield with an
encouraging 45% enantiomeric excess. Unfortunately, re-
ducing the reaction temperature to 0 °C both decreased the
yield and the enantiomeric excess (entry 4). Although addi-
tion of 4 Å MS to the reaction mixture had a positive effect
on the yield, it resulted in an absolutely non-enantioselec-
tive transformation (entry 5). The use of the corresponding
squaramide IV17 could not improve the results (entry 6).
Scheme 3  Three-component synthesis of cycloalka[b]piperidines
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Table 1  Screening of organocatalysts in the three-component reactiona
Entry Catalyst Product (yield)b ee (%)c
1d I 5b (trace) n.d.
2d II no product n.d.
3d III 5b (65%) 45
4d,e III 5b (52%) 37
5d,f III 5b (77%)  0
6d IV 5b (18%) 12
7f V 9 (60%)  6
8 VI 9 (42%) n.d.
9 VII 9 (34%) n.d.
a General reaction conditions: ethyl 2-oxocyclopentanecarboxylate (6a; 50 mg, 1 equiv), methacrolein (8a; 1.2 equiv), allylamine (7e; 1 equiv) and organocata-
lyst I–VII (10 mol%) were stirred at r.t. in toluene (5 mL) for 45 h.
b Products were identified in the crude reaction mixture by 1H NMR spectroscopy. Yields are given for pure product isolated by silica gel chromatography.
c Enantiomeric excesses were determined by HPLC on chiral stationary phase.
d After analysis of the crude reaction mixture, reduction [NaBH4 in THF–AcOH–MeOH (4:2:1) at r.t. for 24 h] was performed to allow the isolation of the pure 
product 9.
e Reaction performed at 0 °C.
f Powdered 4 Å molecular sieves (200 mg) were added to the organocatalytic reaction.
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A series of tertiary amine-based noncovalent bifunc-
tional catalysts were then evaluated: both thioureas V18 and
VI,19 along with squaramide VII,20 did not deliver the ex-
pected compound 5b, but rather the bridged bicycle 9 as
the only product in 34–60% yields (entries 7–9). This new
bicyclic product was formed as only one diastereomer. The
relative configuration of the additional stereogenic center
could be assigned by noticing the disappearance of 3Jax–ax
coupling for the proton on the carbon atom ǳ to the nitro-
gen atom (Figure 3). Unfortunately, this product exhibited
low stability in the HPLC conditions when attempting to
evaluate its enantiomeric excess. Moreover, the only mea-
sure on product 9 formed in the conditions of entry 7
showed that it was virtually racemic.21
Figure 3  Assignment of the relative configurations of product 9
In conclusion, we have taken advantage of the reactivity
of Ǵ-keto esters in Michael additions with enals to develop
multicomponent synthetic routes towards two original bi-
cyclic scaffolds: aminobicyclo[3.2.1]octan-8-ones 4 and cy-
cloalka[b]piperidines 5. We could show that the presence of
an ǳ-substituent on the enal was crucial for the chemose-
lectivity of the reaction, helping to direct it towards the for-
mation of the latter heterocyclic systems. A series of or-
ganocatalysts were evaluated to perform enantioselective
syntheses of these new scaffolds. Even though enantiose-
lectivities remained low, we uncovered an intriguing possi-
bility to obtain one or the other family of products from the
same starting materials depending on the mode of action of
the organocatalyst. Our next efforts will now focus on ex-
tending the possibility to carry out chemo- and enantiose-
lective reactions using organocatalysis.
All commercially available reagents and solvents were used as re-
ceived, except liquid enals that were distilled before use. 2-Benzyl-
acrylaldehyde (8g) was prepared in one step from hydrocinnamalde-
hyde according to the literature.22 Toluene and THF were dried using a
M-Braun SPS-800 system. Petroleum ether (PE) refers to a hydrocar-
bon mixture with a boiling range of 40–60 °C.
Analytical TLC was performed on silica gel 60 F254 aluminum plates
(Macherey-Nagel) containing a 254 nm fluorescent indicator. TLC
plates were visualized by exposure to short wave ultraviolet light
(254 nm) and to vanillin (2 g of vanillin and 4 mL of concd H2SO4 in
100 mL of EtOH) or KMnO4 (1.5 g of KMnO4, 10 g of K2CO3, and 1.25
mL of 10% NaOH in 200 mL of H2O) followed by heating. Flash column
chromatography was performed using silica gel (35–70 Ǿm, 60 Å,
Acros).
1H NMR spectra were recorded on a Bruker AV 400 or Bruker AV 300
spectrometer. Proton chemical shifts are reported in parts per million
(Ƕ scale), and are referenced using residual protium in the NMR sol-
vent [CDCl3: Ƕ = 7.26 (CHCl3)]. 13C NMR spectra were recorded on a
Bruker AV 400 or Bruker AV 300 spectrometer. Carbon chemical shifts
are reported in parts per million (Ƕ scale), and are referenced using
the carbon resonance of the solvent [Ƕ = 77.16 (CHCl3)]. Data are re-
ported as follows: chemical shift (CHn where n is the number of hy-
drogen atoms linked to the carbon atom). HPLC analyses for the deter-
mination of enantiomeric excesses were performed on a Merck-
Hitachi system equipped with the following chiral columns: Chiral-
pak AD-H, (S,S)-Whelk-O1. High-resolution mass spectra (HRMS)
were recorded on a Waters Synapt G2 HDMS apparatus using a posi-
tive electrospray (ESI) ionization source.
Aminobicyclo[3.2.1]octan-8-ones 4a–h; General Procedure
A 100 mL two-necked flask filled with argon was equipped with a re-
flux condenser and a magnetic stirrer bar. Toluene (25 mL) was then
added followed by commercially available activated 4 Å MS (6 g).
Then, ethyl 2-oxocyclopentanecarboxylate (6a; 200 mg, 185 ǾL, 1.28
mmol, 1.0 equiv) was added followed by acrolein (123 ǾL, 1.53 mmol,
1.2 equiv), and the appropriate primary amine 7a–h (1.28 mmol, 1.0
equiv). After complete conversion of 6a, checked by TLC (eluent: see
individual protocols below), the solution was filtered through a short
pad of Celite, which was thoroughly washed with toluene. The solvent
was evaporated under reduced pressure to obtain the crude com-
pound, which was analyzed by 13C NMR spectroscopy to measure the
diastereomeric ratio. Purification by flash column chromatography on
silica gel generally provided the pure product as a single diastereo-
mer.
Scheme 4  Proposed mechanisms for the two multicomponent reac-
tions
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Ethyl 4-(Isopropylamino)-8-oxobicyclo[3.2.1]octane-1-carboxyl-
ate (4a)
Prepared according to the general procedure using i-PrNH2 (7a; 75.7
mg, 110.0 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for 24 h
and the crude product was obtained with a dr of 2.7:1. Purification by
flash chromatography (PE–EtOAc–Et3N, 3:1:0.025) afforded 4a as a
yellow oil; yield: 236 mg (0.934 mmol, 73%); Rf = 0.15 (PE–EtOAc–
Et3N, 3:1:0.025; detection: KMnO4).
1H NMR (300 MHz, CDCl3): Ƕ = 4.16 (q, J = 7.1 Hz, 2 H), 3.14 (ddd, J =
11.3, 4.8, 2.6 Hz, 1 H), 2.78 (dt, J = 12.4, 6.2 Hz, 1 H), 2.61–2.43 (m, 2
H), 2.04 (td, J = 13.6, 5.3 Hz, 1 H), 1.93–1.74 (m, 5 H), 1.39 (tdd, J =
13.8, 11.6, 6.2 Hz, 1 H), 1.22 (t, J = 7.1 Hz, 3 H), 0.97 (dd, J = 6.1, 4.0 Hz,
6 H); NH could not be assigned unambiguously.
13C NMR (75 MHz, CDCl3): Ƕ = 213.0 (C), 171.4 (C), 61.2 (CH2), 60.0
(CH), 57.2 (C), 50.3 (CH), 44.9 (CH), 33.3 (CH2), 27.4 (CH2), 26.3 (CH2),
24.1 (CH3), 22.6 (CH3), 16.7 (CH2), 14.2 (CH3).
HRMS (ESI): m/z calcd for [C14H23NO3 + H]+: 254.1751; found:
254.1754.
Ethyl 4-(Cyclohexylamino)-8-oxobicyclo[3.2.1]octane-1-carboxyl-
ate (4b)
Prepared according to the general procedure using cyclohexylamine
(7b; 127 mg, 146 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for
24 h and the crude product was obtained with a dr of 2.6:1. Purifica-
tion by flash chromatography (PE–EtOAc–Et3N, 2:1:0.025) afforded
4b as a yellow oil; yield: 278 mg (0.947 mmol, 74%); Rf = 0.14 (PE–
EtOAc–Et3N, 2:1:0.025; detection: KMnO4).
1H NMR (300 MHz, CDCl3): Ƕ = 4.12 (q, J = 7.1 Hz, 2 H), 3.16 (ddd, J =
11.2, 4.7, 2.5 Hz, 1 H), 2.58–2.41 (m, 2 H), 2.35 (ddd, J = 10.3, 7.1, 3.6
Hz, 1 H), 1.99 (td, J = 13.6, 5.7 Hz, 1 H), 1.90–1.70 (m, 6 H), 1.62 (d, J =
11.2 Hz, 3 H), 1.52 (d, J = 11.4 Hz, 1 H), 1.36 (ddd, J = 25.3, 13.5, 6.3 Hz,
1 H), 1.20 (t, J = 7.1 Hz, 3 H), 1.15–0.81 (m, 5 H); NH could not be as-
signed unambiguously.
13C NMR (75 MHz, CDCl3): Ƕ = 213.0 (C), 171.3 (C), 61.0 (CH2), 59.5
(CH), 57.1 (C), 53.0 (CH), 50.4 (CH), 34.6 (CH2), 33.3 (CH2), 33.2 (CH2),
27.3 (CH2), 26.3 (CH2), 26.0 (CH2), 25.1 (CH2), 24.8 (CH2), 16.6 (CH2),
14.1 (CH3).
HRMS (ESI): m/z calcd for [C17H27NO3 + H]+: 294.2064; found:
294.2066.
Ethyl 4-(tert-Butylamino)-8-oxobicyclo[3.2.1]octane-1-carboxyl-
ate (4c)
Prepared according to the general procedure using t-BuNH2 (7c; 93.6
mg, 135 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for 23 h and
the crude product was obtained with a dr of 2.8:1. Purification by
flash chromatography (PE–EtOAc–Et3N, 2:1:0.025) afforded 4c as a
yellow oil; yield: 246 mg (0.922 mmol, 72%); Rf = 0.53 (PE–EtOAc–
Et3N, 2:1:0.025; detection: KMnO4).
1H NMR (300 MHz, CDCl3): Ƕ = 4.17 (q, J = 7.1 Hz, 2 H), 3.12 (ddd, J =
11.2, 5.0, 2.6 Hz, 1 H), 2.59–2.43 (m, 1 H), 2.43–2.35 (m, 1 H), 2.07–
1.74 (m, 6 H), 1.46 (ddd, J = 25.3, 13.5, 6.2 Hz, 1 H), 1.24 (t, J = 7.1 Hz, 3
H), 1.03 (d, J = 5.1 Hz, 9 H); NH could not be assigned unambiguously.
13C NMR (75 MHz, CDCl3): Ƕ = 212.7 (C), 171.6 (C), 61.1 (CH2), 57.5 (C),
57.0 (CH), 54.8 (CH), 51.2 (C), 33.2 (CH2), 30.0 (3 CH3), 28.4 (CH2), 27.3
(CH2), 17.2 (CH2), 14.3 (CH3).
HRMS (ESI): m/z calcd for [C15H25NO3 + H]+: 268.1907; found:
268.1912.
Ethyl 8-Oxo-4-(propylamino)bicyclo[3.2.1]octane-1-carboxylate 
(4d)
Prepared according to the general procedure using n-PrNH2 (7d; 75.7
mg, 105 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for 24 h and
the crude product was obtained with a dr of 2.3:1. Purification by
flash chromatography (PE–EtOAc–Et3N, 3:1:0.025) afforded 4d as a
yellow oil; yield: 204 mg (0.806 mmol, 63%); Rf = 0.42 (PE–EtOAc–
Et3N, 3:1:0.025; detection: UV, vanillin).
1H NMR (400 MHz, CDCl3): Ƕ = 4.15 (q, J = 7.1 Hz, 2 H), 3.03 (ddd, J =
11.4, 5.0, 2.7 Hz, 1 H), 2.57 (dd, J = 6.1, 3.0 Hz, 1 H), 2.55–2.37 (m, 3 H),
2.04 (tdd, J = 13.7, 5.4, 1.5 Hz, 1 H), 1.91 (dd, J = 6.2, 1.3 Hz, 1 H), 1.89–
1.77 (m, 4 H), 1.49–1.32 (m, 3 H), 1.22 (t, J = 7.1 Hz, 3 H), 0.85 (t, J = 7.4
Hz, 3 H); NH could not be assigned unambiguously.
13C NMR (101 MHz, CDCl3): Ƕ = 213.1 (C), 171.4 (C), 63.0 (CH), 61.1
(CH2), 57.1 (C), 50.1 (CH), 48.7 (CH2), 33.3 (CH2), 27.4 (CH2), 25.8
(CH2), 23.4 (CH2), 16.6 (CH2), 14.2 (CH3), 11.7 (CH3).
HRMS (ESI): m/z calcd for [C14H23NO3 + H]+: 254.1750; found:
254.1750.
Ethyl 4-(Allylamino)-8-oxobicyclo[3.2.1]octane-1-carboxylate (4e)
Prepared according to the general procedure using allylamine (7e;
73.1 mg, 95.8 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for 22 h
and the crude product was obtained with a dr of 2.4:1. Purification by
flash chromatography (PE–EtOAc–Et3N, 3:1:0.025) afforded 4e as a
yellow oil; yield: 212 mg (0.845 mmol, 66%); Rf = 0.24 (PE–EtOAc–
Et3N, 3:1:0.025; detection: UV, vanillin).
1H NMR (400 MHz, CDCl3): Ƕ = 5.83 (ddt, J = 16.2, 10.2, 5.9 Hz, 1 H),
5.16 (ddd, J = 17.2, 3.1, 1.5 Hz, 1 H), 5.08 (ddd, J = 10.2, 2.8, 1.4 Hz, 1
H), 4.19 (q, J = 7.1 Hz, 2 H), 3.33–3.04 (m, 3 H), 2.63–2.49 (m, 2 H),
2.07 (tdd, J = 13.7, 5.3, 1.4 Hz, 1 H), 1.97–1.83 (m, 5 H), 1.48 (tdd, J =
13.8, 11.6, 6.2 Hz, 1 H), 1.26 (t, J = 7.1 Hz, 3 H); NH could not be as-
signed unambiguously.
13C NMR (101 MHz, CDCl3): Ƕ = 212.9 (C), 171.5 (C), 136.5 (CH), 116.3
(CH2), 62.4 (CH), 61.3 (CH2), 57.2 (C), 50.2 (CH), 49.5 (CH2), 33.4 (CH2),
27.4 (CH2), 25.8 (CH2), 16.8 (CH2), 14.3 (CH3).
HRMS (ESI): m/z calcd for [C14H21NO3 + H]+: 252.1594; found:
252.1599.
Ethyl 4-(Benzylamino)-8-oxobicyclo[3.2.1]octane-1-carboxylate 
(4f)
Prepared according to the general procedure using benzylamine (7f;
137 mg, 140 ǾL, 1.28 mmol, 1.0 equiv). The reaction was run for 24 h
and the crude product was obtained with a dr of 2.6:1. Purification by
flash chromatography (PE–EtOAc-Et3N, 2:1:0.025) afforded 4f as a
yellow oil; yield: 278 mg (0.922 mmol, 72%); Rf = 0.48 (PE–EtOAc–
Et3N, 2:1:0.025; detection: UV, vanillin).
1H NMR (300 MHz, CDCl3): Ƕ = 7.33–7.25 (m, 5 H), 4.19 (q, J = 7.1 Hz, 2
H), 3.73 (q, J = 13.2 Hz, 2 H), 3.15 (ddd, J = 11.3, 5.0, 2.7 Hz, 1 H), 2.68–
2.61 (m, 1 H), 2.59–2.51 (m, 1 H), 2.06 (ddd, J = 13.6, 5.3, 1.3 Hz, 1 H),
2.00–1.87 (m, 5 H), 1.50 (ddd, J = 25.3, 13.5, 6.3 Hz, 1 H), 1.25 (t, J = 7.1
Hz, 3 H); NH could not be assigned unambiguously.
13C NMR (75 MHz, CDCl3): Ƕ = 213.0 (C), 171.5 (C), 140.1 (C), 128.6 (2
CH), 128.1 (2 CH), 127.2 (CH), 62.5 (CH), 61.3 (CH2), 57.2(C), 51.0
(CH2), 50.1 (CH), 33.4 (CH2), 27.4 (CH2), 25.7 (CH2), 16.8 (CH2), 14.3
(CH3).
HRMS (ESI): m/z calcd for [C18H23NO3 + H]+: 302.1750; found:
302.1749.
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Ethyl 4-[(3,4-Dimethoxyphenethyl)amino]-8-oxobicyclo[3.2.1]oc-
tane-1-carboxylate (4g)
Prepared according to the general procedure using 3,4-dimethoxy-
phenethylamine (7g; 232 mg, 217 ǾL, 1.28 mmol, 1.0 equiv). The re-
action was run for 24 h and the crude product was obtained with a dr
of 2.2:1. Purification by flash chromatography (PE–EtOAc–Et3N,
2:1:0.025) afforded 4g as a yellow oil; yield: 379 mg (1.010 mmol,
79%); Rf = 0.06 (PE–EtOAc–Et3N, 2:1:0.025; detection: UV, vanillin).
1H NMR (300 MHz, CDCl3): Ƕ = 6.75–6.68 (m, 1 H), 6.67–6.60 (m, 2 H),
4.10 (q, J = 7.1 Hz, 2 H), 3.77 (d, J = 3.8 Hz, 6 H), 3.00 (ddd, J = 11.3, 4.8,
2.5 Hz, 1 H), 2.82–2.53 (m, 4 H), 2.53–2.35 (m, 2 H), 2.11–1.67 (m, 6
H), 1.35 (ddd, J = 18.9, 13.6, 6.8 Hz, 1 H), 1.18 (t, J = 7.1 Hz, 3 H); NH
could not be assigned unambiguously.
13C NMR (75 MHz, CDCl3): Ƕ = 212.8 (C), 171.2 (C), 148.8 (C), 147.4 (C),
132.1 (C), 120.4 (CH), 111.8 (CH), 111.3 (CH), 62.7 (CH), 61.0 (CH2),
56.9 (C), 55.8 (CH3), 55.7 (CH3), 49.8 (CH), 47.8 (CH2), 35.7 (CH2), 33.1
(CH2), 27.1 (CH2), 25.5 (CH2), 16.4 (CH2), 14.0 (CH3).
HRMS (ESI): m/z calcd for [C21H29N2O5 + H]+: 376.2018; found:
376.2119.
Ethyl 4-{[2-(1H-Indol-3-yl)ethyl]amino}-8-oxobicyclo[3.2.1]oc-
tane-1-carboxylate (4h)
Prepared according to the general procedure using tryptamine (7h;
205 mg, 1.28 mmol, 1.0 equiv). The reaction was run for 23 h and the
crude product was obtained with a dr of 2.3:1. Purification by flash
chromatography (PE–EtOAc, 2:1) afforded 4h as a yellow oil; yield:
331 mg (0.934 mmol, 73%); Rf = 0.05 (PE–EtOAc, 2:1; detection: UV,
vanillin).
1H NMR (300 MHz, CDCl3): Ƕ (major diastereomer) = 8.36 (s, 1 H),
7.64–7.54 (m, 1 H), 7.39–7.30 (m, 1 H), 7.22–7.16 (m, 2 H), 7.03–6.96
(m, 1 H), 4.29–4.13 (m, 2 H), 3.10 (ddd, J = 11.4, 5.0, 2.6 Hz, 1 H), 3.03–
2.81 (m, 4 H), 2.62–2.41 (m, 2 H), 2.15–1.52 (m, 7 H), 1.49–1.35 (m, 1
H), 1.30–1.23 (m, 3 H); Ƕ (minor diastereomer) = 8.27 (s, 1 H), 7.64–
7.54 (m, 1 H), 7.39–7.30 (m, 1 H), 7.22–7.16 (m, 2 H), 7.03–6.96 (m, 1
H), 4.29–4.13 (m, 2 H), 3.23–3.14 (m, 1 H), 3.03–2.81 (m, 4 H), 2.62–
2.41 (m, 2 H), 2.15–1.52 (m, 7 H), 1.49–1.35 (m, 1 H), 1.30–1.23 (m, 3
H).
13C NMR (75 MHz, CDCl3): Ƕ (major diastereomer) = 213.3 (C), 171.5
(C), 136.5 (C), 127.4 (C), 122.3 (CH), 122.0 (CH),119.4 (CH), 118.7
(CH), 113.3 (C), 111.3 (CH), 62.9 (CH), 61.4 (CH2), 57.2 (C), 50.0 (CH),
46.7 (CH2), 33.3 (CH2), 27.3 (CH2), 25.8 (CH2), 25.6 (CH2), 16.5 (CH2),
14.2 (CH3); Ƕ (minor diastereomer) = 212.5 (C), 171.5 (C), 136.4 (C),
127.4 (C), 122.4 (CH), 121.8 (CH), 119.1 (CH), 118.7 (CH), 113.6 (C),
111.3 (CH), 65.1 (CH), 61.3 (CH2), 57.5 (C), 49.8 (CH), 47.3 (CH2), 34.3
(CH2), 26.3 (CH2), 25.7 (CH2), 23.3 (CH2), 20.4 (CH2), 14.2 (CH3).
HRMS (ESI): m/z calcd for [C21H26N2O3 + H]+: 355.2016; found:
355.2021.
Cycloalka[b]piperidines 5a–i; General Procedure
A 100 mL two-necked flask filled with argon was equipped with a re-
flux condenser and a magnetic stirrer bar. Toluene (25 mL) was then
added followed by commercially available activated 4 Å MS (6 g).
Then, the Ǵ-keto ester 6a,h (1.28 or 1.17 mmol, 1.0 equiv) was added
followed by the ǳ,Ǵ-unsaturated aldehyde 8 (1.54 or 1.41 mmol, 1.2
equiv), and the appropriate primary amine 7d–h (1.28 or 1.17 mmol,
1.0 equiv). After complete conversion of the Ǵ-keto ester, checked by
TLC (eluent: see individual protocols below), the solution was filtered
through a short pad of Celite, which was thoroughly washed with tol-
uene. The solvent was evaporated under reduced pressure to obtain
the crude dieneamine. In a 50 mL two-necked flask equipped with a
magnetic stirring bar were added the crude dieneamine dissolved in
THF, and NaBH4 (6 equiv) under argon. Then, AcOH was slowly added
(caution: gas evolution), followed by EtOH. The resultant suspension
was stirred at r.t. for 24 h. After completion of the reaction, most of
the solvent was removed under reduced pressure. H2O (15 mL), 10%
aq NaOH (15 mL), and Et2O (15 mL) were added. The organic layer was
separated and the aqueous phase was further extracted with Et2O (2 ×
15 mL). The combined organic layers were then washed with H2O (2 ×
10 mL), brine (15 mL), and dried (Na2SO4). The solvent was evaporated
giving the crude product, which was analyzed by 13C NMR spectrosco-
py to measure the diastereomeric ratio. Purification by flash column
chromatography on silica gel provided the pure product.
Ethyl 3-Methyl-1-propyloctahydro-1H-cyclopenta[b]pyridine-4a-
carboxylate (5a)
Prepared according to the general procedure using ethyl 2-oxocyclo-
pentanecarboxylate (6a; 200 mg, 185 ǾL, 1.28 mmol, 1.0 equiv),
methacrolein (8a; 108 mg, 127 ǾL, 1.54 mmol, 1.2 equiv), and n-
PrNH2 (7d; 76 mg, 105 ǾL, 1.28 mmol, 1.0 equiv). The reduction was
carried out with NaBH4 (265 mg) in THF (5 mL), AcOH (2.8 mL), and
EtOH (1.4 mL). The crude product was obtained with a dr of 10:1. Pu-
rification by flash chromatography (PE–EtOAc, 1:1) afforded 5a as a
yellow oil; yield: 237 mg (0.934 mmol, 73%); Rf = 0.06 (PE–EtOAc, 1:1;
detection: KMnO4).
1H NMR (300 MHz, CDCl3): Ƕ = 4.07 (qd, J = 7.1, 1.8 Hz, 2 H), 2.75 (d, J =
11.1 Hz, 1 H), 2.61 (ddd, J = 12.3, 8.9, 7.3 Hz, 1 H), 2.42 (d, J = 13.1 Hz,
1 H), 2.24 (ddd, J = 11.8, 10.9, 6.0 Hz, 1 H), 2.17–2.07 (m, 1 H), 2.01
(dd, J = 11.1, 3.7 Hz, 1 H), 1.97–1.79 (m, 3 H), 1.81–1.70 (m, 1 H), 1.66–
1.53 (m, 2 H), 1.55–1.33 (m, 3 H), 1.31 (dd, J = 13.1, 5.4 Hz, 1 H), 1.23
(t, J = 7.1 Hz, 3 H), 0.95 (d, J = 7.4 Hz, 3 H), 0.86 (t, J = 7.3 Hz, 3 H).
13C NMR (75 MHz, CDCl3): Ƕ = 175.9 (C), 73.3 (CH), 60.3 (CH2), 59.6
(CH2), 57.3 (CH2), 50.9 (C), 40.4 (CH2), 37.2 (CH2), 29.5 (CH), 26.1
(CH2), 19.6 (CH3), 19.5 (CH2), 19.1 (CH2), 14.2 (CH3), 12.1 (CH3).
HRMS (ESI): m/z calcd for [C15H27NO2 + H]+: 254.2114; found:
254.2113.
Ethyl 1-Allyl-3-methyloctahydro-1H-cyclopenta[b]pyridine-4a-
carboxylate (5b)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), methacrolein (8a; 108 mg, 127 ǾL, 1.54
mmol, 1.2 equiv), and allylamine (7e; 73.1 mg, 95.8 ǾL, 1.28 mmol,
1.0 equiv). The reduction was carried out with NaBH4 (318 mg) in THF
(6 mL), AcOH (4.8 mL), and EtOH (2.4 mL). The crude product was ob-
tained with a dr of 10:1. Purification by flash chromatography (PE–
EtOAc, 1:3) afforded 5b as a yellow oil; yield: 257 mg (1.02 mmol,
80%); Rf = 0.05 (PE–EtOAc, 1:3; detection: KMnO4).
1H NMR (400 MHz, CDCl3): Ƕ = 5.94 (dddd, J = 17.4, 10.2, 7.7, 5.3 Hz, 1
H), 5.16 (ddd, J = 17.2, 3.1, 1.9 Hz, 1 H), 5.09 (ddd, J = 10.2, 2.8, 1.4 Hz,
1 H), 4.10 (q, J = 7.1 Hz, 2 H), 3.40 (ddt, J = 13.9, 5.3, 1.6 Hz, 1 H), 2.87
(dd, J = 13.9, 7.7 Hz, 1 H), 2.73 (dt, J = 11.3, 1.6 Hz, 1 H), 2.44 (dt, J =
13.1, 1.6 Hz, 1 H), 2.27 (tdd, J = 11.2, 9.1, 7.9 Hz, 1 H), 2.07 (dd, J = 11.3,
3.9 Hz, 1 H), 1.95 (dd, J = 12.0, 8.1 Hz, 1 H), 1.94–1.80 (m, 3 H), 1.68–
1.59 (m, 2 H), 1.49–1.39 (m, 1 H), 1.32 (dd, J = 13.2, 5.5 Hz, 1 H), 1.23
(t, J = 7.1 Hz, 3 H), 0.96 (d, J = 7.4 Hz, 3 H).
13C NMR (101 MHz, CDCl3): Ƕ = 175.8 (C), 135.7 (CH), 117.1 (CH2), 72.9
(CH), 60.6 (CH2), 59.6 (CH2), 59.0 (CH2), 50.8 (C), 40.2 (CH2), 37.1
(CH2), 29.5 (CH), 26.0 (CH2), 19.5 (CH2), 19.5 (CH3), 14.2 (CH3).
HRMS (ESI): m/z calcd for [C15H25NO2 + H]+: 252.1958; found:
252.1959.
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Ethyl 1-Benzyl-3-methyloctahydro-1H-cyclopenta[b]pyridine-4a-
carboxylate (5c)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), methacrolein (8a; 108 mg, 127 ǾL, 1.54
mmol, 1.2 equiv), and benzylamine (7f; 137 mg, 140 ǾL, 1.28 mmol,
1.0 equiv). The reduction was carried out with NaBH4 (265 mg) in THF
(5 mL), AcOH (3.4 mL), and EtOH (1.7 mL). The crude product was ob-
tained with a dr of 10:1. Purification by flash chromatography (PE–
EtOAc, 1:3) afforded 5c as a yellow oil; yield: 301 mg (0.998 mmol,
78%); Rf = 0.14 (PE–EtOAc, 1:3; detection: KMnO4).
1H NMR (300 MHz, CDCl3): Ƕ = 7.45–7.36 (m, 1 H), 7.35–7.13 (m, 4 H),
4.10 (q, J = 7.1 Hz, 2 H), 4.04 (d, J = 13.5 Hz, 1 H), 3.07 (d, J = 13.5 Hz, 1
H), 2.60 (d, J = 11.0 Hz, 1 H), 2.46 (d, J = 13.1 Hz, 1 H), 2.37–2.21 (m, 1
H), 2.08 (dd, J = 12.0, 7.9 Hz, 1 H), 1.98–1.79 (m, 4 H), 1.73–1.59 (m, 2
H), 1.54–1.43 (m, 1 H), 1.36 (dd, J = 13.1, 5.3 Hz, 1 H), 1.28 (d, J = 7.1
Hz, 3 H), 0.92 (d, J = 7.3 Hz, 3 H).
13C NMR (75 MHz, CDCl3): Ƕ = 176.0 (C), 140.4 (C), 128.8 (2 CH), 128.1
(2 CH), 126.6 (CH), 73.6 (CH), 61.0 (CH2), 60.0 (CH2), 59.7 (CH2), 51.2
(C), 40.6 (CH2), 37.3 (CH2), 29.5 (CH2), 26.4 (CH2), 19.7 (CH), 19.3
(CH3), 14.3 (CH3).
HRMS (ESI): m/z calcd for [C19H27NO2 + H]+: 302.2114; found:
302.2115.
Ethyl 1-(3,4-Dimethoxyphenethyl)-3-methyloctahydro-1H-cyclo-
penta[b]pyridine-4a-carboxylate (5d)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), methacrolein (8a; 108 mg, 127 ǾL, 1.54
mmol, 1.2 equiv), and 3,4-dimethoxyphenethylamine (7g; 232 mg,
217 ǾL, 1.28 mmol, 1.0 equiv). The reduction was carried out with
NaBH4 (325 mg) in THF (9 mL), AcOH (6 mL), and EtOH (3 mL). The
crude product was obtained with a dr of 10:1. Purification by flash
chromatography (PE–EtOAc, 1:3) afforded 5d as a yellow oil; yield:
427 mg (1.14 mmol, 89%); Rf = 0.10 (PE–EtOAc, 1:3; detection: UV,
vanillin).
1H NMR (400 MHz, CDCl3): Ƕ = 6.79–6.72 (m, 3 H), 4.07 (q, J = 7.1 Hz, 2
H), 3.85 (d, J = 10.6 Hz, 6 H), 2.94 (ddd, J = 12.4, 10.1, 6.2 Hz, 1 H), 2.85
(d, J = 11.0 Hz, 1 H), 2.75–2.69 (m, 2 H), 2.44 (ddd, J = 11.8, 9.8, 5.6 Hz,
2 H), 2.36–2.24 (m, 1 H), 2.17 (dd, J = 11.0, 3.8 Hz, 1 H), 2.04–1.93 (m,
2 H), 1.90–1.79 (m, 2 H), 1.64 (ddd, J = 11.1, 9.1, 4.1 Hz, 2 H), 1.49–
1.40 (m, 1 H), 1.37–1.30 (m, 1 H), 1.23 (t, J = 7.1 Hz, 3 H), 0.97 (d, J =
7.4 Hz, 3 H).
13C NMR (75 MHz, CDCl3): Ƕ = 175.7 (C), 148.8 (C), 147.2 (C), 134.0 (C),
120.6 (CH), 112.4 (CH), 111.3 (CH), 73.2 (CH), 60.6 (CH2), 59.6 (CH2),
57.7 (CH2), 56.0 (CH3), 55.9 (CH3), 50.8 (C), 40.3 (CH2), 37.1 (CH2), 32.1
(CH2), 29.5 (CH), 26.1 (CH2), 19.6 (CH3), 19.5 (CH2), 14.2 (CH3).
HRMS (ESI): m/z calcd for [C22H33NO4 + H]+: 376.2482; found:
376.2480.
Ethyl 1-[2-(1H-Indol-3-yl)ethyl]-3-methyloctahydro-1H-cyclopen-
ta[b]pyridine-4a-carboxylate (5e)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), methacrolein (8a; 108 mg, 127 ǾL, 1.54
mmol, 1.2 equiv), and tryptamine (7h; 205 mg, 1.28 mmol, 1.0 equiv).
The reduction was carried out with NaBH4 (258 mg) in THF (8 mL),
AcOH (4 mL), and EtOH (2 mL). The crude product was obtained with
a dr of 5:1. Purification by flash chromatography (PE–EtOAc 1:3) af-
forded 5e as a yellow oil, yield: 363 mg (1.02 mmol, 80%); Rf = 0.24
(PE–EtOAc, 1:3; detection: UV, vanillin).
1H NMR (300 MHz, CDCl3): Ƕ = 8.05 (s, 1 H), 7.61 (d, J = 7.8 Hz, 1 H),
7.35 (d, J = 7.9 Hz, 1 H), 7.24–7.07 (m, 3 H), 4.12 (q, J = 7.1 Hz, 2 H),
3.13 (ddd, J = 12.0, 9.8, 6.6 Hz, 1 H), 2.94 (dd, J = 14.5, 7.5 Hz, 3 H), 2.59
(ddd, J = 12.4, 9.0, 5.1 Hz, 1 H), 2.49 (d, J = 13.1 Hz, 1 H), 2.36 (ddd, J =
19.4, 11.2, 8.8 Hz, 1 H), 2.25–2.17 (m, 1 H), 2.13–1.79 (m, 4 H), 1.75–
1.61 (m, 2 H), 1.51 (dd, J = 12.3, 9.2 Hz, 1 H), 1.40 (dd, J = 13.1, 5.4 Hz,
1 H), 1.27 (t, J = 7.2 Hz, 3 H), 1.01 (d, J = 7.4 Hz, 3 H).
13C NMR (75 MHz, CDCl3): Ƕ = 176.0 (C), 136.3 (C), 127.9 (C), 122.2
(CH), 121.9 (CH), 119.0 (CH), 118.9 (CH), 115.1 (C), 111.1 (CH), 73.3
(CH), 60.3 (CH2), 59.7 (CH2), 56.0 (CH2), 50.9 (C), 40.4 (CH2), 37.2
(CH2), 29.6 (CH), 26.2 (CH2), 21.6 (CH2), 19.6 (CH2), 19.6 (CH3), 14.2
(CH3).
HRMS (ESI): m/z calcd for [C22H30N2O2 + H]+: 355.2380; found:
355.2378.
Ethyl 1-Allyl-3-ethyloctahydro-1H-cyclopenta[b]pyridine-4a-car-
boxylate (5f)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), 2-ethylacrolein (8f; 142 mg, 150 ǾL, 1.54
mmol, 1.2 equiv), and allylamine (7e; 73.1 mg, 95.8 ǾL, 1.28 mmol,
1.0 equiv). The reduction was carried out with NaBH4 (258 mg) in THF
(4 mL), AcOH (2.5 mL), and EtOH (1.3 mL). The crude product was ob-
tained with a dr of 10:1. Purification by flash chromatography (PE–
EtOAc, 1:5) afforded 5f as a yellow oil; yield: 217 mg (0.819 mmol,
64%); Rf = 0.05 (PE–EtOAc, 1:5; detection: KMnO4).
1H NMR (400 MHz, CDCl3): Ƕ = 5.94 (dddd, J = 17.6, 10.2, 7.6, 5.3 Hz, 1
H), 5.17 (ddd, J = 17.2, 3.0, 1.9 Hz, 1 H), 5.10 (ddd, J = 10.2, 2.8, 1.4 Hz,
1 H), 4.16–3.99 (m, 2 H), 3.40 (ddt, J = 13.9, 5.3, 1.6 Hz, 1 H), 2.88 (ddd,
J = 13.6, 6.6, 4.8 Hz, 2 H), 2.54 (d, J = 13.3 Hz, 1 H), 2.31–2.20 (m, 1 H),
2.04–1.94 (m, 2 H), 1.92–1.85 (m, 1 H), 1.81 (ddd, J = 16.0, 9.2, 5.1 Hz,
1 H), 1.71–1.57 (m, 3 H), 1.57–1.50 (m, 1 H), 1.48–1.34 (m, 2 H), 1.31–
1.27 (m, 1 H), 1.24 (t, J = 7.1 Hz, 3 H), 0.85 (t, J = 7.3 Hz, 3 H).
13C NMR (101 MHz, CDCl3): Ƕ = 175.7 (C), 135.7 (CH), 117.2 (CH2), 73.1
(CH), 59.7 (CH2), 59.0 (CH2), 58.3 (CH2), 51.1 (C), 38.3 (CH2), 37.4 (CH),
37.2 (CH2), 26.0 (CH2), 25.6 (CH2), 19.5 (CH2), 14.2 (CH3), 13.1 (CH3).
HRMS (ESI): m/z calcd for [C16H27NO2 + H]+: 266.2115; found:
266.2114.
Ethyl 1-Allyl-3-benzyloctahydro-1H-cyclopenta[b]pyridine-4a-
carboxylate (5g)
Prepared according to the general procedure using 6a (200 mg, 185
ǾL, 1.28 mmol, 1.0 equiv), 2-benzylacrylaldehyde (8g; 225 mg, 1.54
mmol, 1.2 equiv), and allylamine (7e; 73.1 mg, 95.8 ǾL, 1.28 mmol,
1.0 equiv). The reduction was carried out with NaBH4 (258 mg) in THF
(4 mL), AcOH (2.5 mL), and EtOH (1.3 mL). The crude product was ob-
tained with a dr of 10:1. Purification by flash chromatography (PE–
Et2O, 1:4) afforded 5g as a yellow oil; yield: 268 mg (0.819 mmol,
64%); Rf = 0.05 (PE–Et2O, 1:4; detection: KMnO4).
1H NMR (400 MHz, CDCl3): Ƕ = 7.38–7.33 (m, 2 H), 7.29–7.23 (m, 3 H),
6.04 (dddd, J = 17.3, 10.2, 7.9, 5.2 Hz, 1 H), 5.25–5.13 (m, 2 H), 4.32–
4.13 (m, 2 H), 3.53 (ddt, J = 13.7, 5.1, 1.6 Hz, 1 H), 2.93–2.87 (m, 2 H),
2.84–2.72 (m, 2 H), 2.64 (dd, J = 13.2, 4.0 Hz, 1 H), 2.41 (tdd, J = 11.2,
10.2, 6.5 Hz, 1 H), 2.16–2.09 (m, 1 H), 2.04 (ddd, J = 12.7, 9.2, 3.8 Hz, 2
H), 2.00–1.88 (m, 2 H), 1.83–1.72 (m, 2 H), 1.62–1.51 (m, 2 H), 1.35 (t,
J = 7.1 Hz, 3 H).
13C NMR (75 MHz, CDCl3): Ƕ = 175.6 (C), 142.4 (C), 135.8 (CH), 129.3
(2 CH), 128.2 (2 CH), 125.8 (CH), 117.2 (CH2), 73.3 (CH), 59.8 (CH2),
59.0 (CH2), 56.7 (CH2), 51.2 (C), 39.9 (CH2), 38.9 (CH2), 37.6 (CH), 37.2
(CH2), 26.0 (CH2), 19.6 (CH2), 14.2 (CH3).
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HRMS (ESI): m/z calcd for [C21H29NO2 + H]+: 328.2271; found:
328.2268.
Ethyl 1-Allyl-3-methyldecahydroquinoline-4a-carboxylate (5h)
Prepared according to the general procedure using ethyl 2-oxocyclo-
hexanecarboxylate (6h; 200 mg, 187 ǾL, 1.17 mmol, 1.0 equiv), meth-
acrolein (8a; 98.8 mg, 116 ǾL, 1.41 mmol, 1.2 equiv), and allylamine
(7e; 66.8 mg, 87.5 ǾL, 1.17 mmol, 1.0 equiv). The reduction was car-
ried out with NaBH4 (240 mg) in THF (5 mL), AcOH (2.7 mL), and EtOH
(1.35 mL). The crude product was obtained with a dr of 6:1. Purifica-
tion by flash chromatography (PE–Et2O, 1:1) afforded 5h as a yellow
oil; yield: 276 mg (1.04 mmol, 89%); Rf = 0.05 (PE–Et2O, 1:1; detec-
tion: KMnO4).
1H NMR (400 MHz, CDCl3): Ƕ = 5.96–5.84 (m, 1 H), 5.17–5.07 (m, 2 H),
4.15–4.05 (m, 2 H), 3.34 (dd, J = 14.5, 5.9 Hz, 1 H), 3.19 (dd, J = 14.5,
7.0 Hz, 1 H), 2.66 (dt, J = 11.3, 1.8 Hz, 1 H), 2.38 (dd, J = 11.3, 3.7 Hz, 1
H), 2.33–2.21 (m, 1 H), 2.18 (dt, J = 13.5, 1.9 Hz, 1 H), 1.97 (dd, J = 12.1,
4.0 Hz, 1 H), 1.92–1.78 (m, 4 H), 1.45 (dd, J = 5.9, 3.0 Hz, 1 H), 1.34 (dd,
J = 13.5, 5.3 Hz, 1 H), 1.25 (t, J = 7.1 Hz, 3 H), 1.28–1.21 (m, 1 H), 1.16–
1.09 (m, 2 H), 0.98 (d, J = 7.3 Hz, 3 H).
13C NMR (101 MHz, CDCl3): Ƕ = 175.8 (C), 135.5 (CH), 117.0 (CH2), 68.9
(CH), 60.3 (CH2), 59.6 (CH2), 56.0 (CH2), 46.0 (C), 42.9 (CH2), 38.7
(CH2), 29.1 (CH), 26.1 (CH2), 25.0 (CH2), 22.1 (CH2), 19.1 (CH3), 14.3
(CH3).
HRMS (ESI): m/z calcd for [C16H27NO2 + H]+: 266.2115; found:
266.2116.
Ethyl 1-[2-(1H-indol-3-yl)ethyl]-3-methyldecahydroquinoline-4a-
carboxylate (5i)
Prepared according to the general procedure using 6h (200 mg, 187
ǾL, 1.17 mmol, 1.0 equiv), methacrolein (8a; 98.8 mg, 116 ǾL, 1.41
mmol, 1.2 equiv), and tryptamine (7h; 188 mg, 1.17 mmol, 1.0 equiv).
The reduction was carried out with NaBH4 (228 mg) in THF (5 mL),
AcOH (3 mL), and EtOH (1.5 mL). The crude product was obtained
with a dr of 6:1. Purification by flash chromatography (PE–EtOAc,
1:3) afforded 5i as a yellow oil; yield: 310 mg (0.842 mmol, 72%); Rf =
0.05 (PE–EtOAc, 1:3; detection: KMnO4).
1H NMR (400 MHz, CDCl3): Ƕ = 8.02 (s, 1 H), 7.60 (d, J = 7.9 Hz, 1 H),
7.35 (d, J = 8.0 Hz, 1 H), 7.20–7.15 (m, 1 H), 7.13–7.07 (m, 2 H), 4.18–
4.08 (m, 2 H), 3.16–3.06 (m, 1 H), 3.02–2.89 (m, 2 H), 2.87–2.75 (m, 2
H), 2.65 (dd, J = 11.1, 3.6 Hz, 1 H), 2.37 (ddd, J = 25.2, 12.6, 4.3 Hz, 1 H),
2.23 (d, J = 13.5 Hz, 1 H), 2.18–2.10 (m, 1 H), 1.98–1.81 (m, 4 H), 1.50–
1.45 (m, 1 H), 1.41 (dd, J = 13.5, 5.3 Hz, 1 H), 1.27 (t, J = 7.1 Hz, 3 H),
1.20–1.15 (m, 2 H), 1.02 (d, J = 7.3 Hz, 3 H), 0.97–0.88 (m, 1 H).
13C NMR (101 MHz, CDCl3): Ƕ = 176.0 (C), 136.3 (C), 127.9 (C), 121.9
(CH), 121.6 (CH), 119.2 (CH), 118.9 (CH), 115.1 (C), 111.2 (CH), 68.7
(CH), 60.0 (CH2), 59.6 (CH2), 53.0 (CH2), 46.1 (C), 43.0 (CH2), 38.8
(CH2), 29.1 (CH), 26.2 (CH2), 25.2 (CH2), 22.2 (CH2), 19.8 (CH2), 19.2
(CH3), 14.3 (CH3).
HRMS (ESI): m/z calcd for [C23H32N2O2 + H]+: 369.2537; found:
369.2536.
Enantioenriched Ethyl 1-Allyl-3-methyloctahydro-1H-cyclopen-
ta[b]pyridine-4a-carboxylate (5b)
A 25 mL flask filled with argon was equipped with a magnetic stirrer
bar. Toluene (5 mL) was then added followed by organocatalyst III
(12.3 mg, 0.032 mmol, 10 mol%). Then, ethyl 2-oxocyclopentanecar-
boxylate (6a; 50 mg, 46.3 ǾL, 0.32 mmol, 1.0 equiv) was added fol-
lowed by methacrolein (8a; 31.2 ǾL, 0.38 mmol, 1.2 equiv), and allyl-
amine (7e; 24.0 ǾL, 0.32 mmol, 1.0 equiv). After complete conversion
of the Ǵ-keto ester, checked by TLC (eluent: PE–EtOAc, 1:3), the solu-
tion was filtered through a short pad of Celite, which was thoroughly
washed with toluene. The solvent was evaporated under reduced
pressure to obtain the crude dieneamine. In a 50 mL flask equipped
with a magnetic stirring bar, were added the crude dieneamine dis-
solved in THF (2 mL), and NaBH4 (72.6 mg, 1.92 mmol, 6 equiv) under
argon. Then, AcOH (1 mL) was slowly added (caution: gas evolution),
followed by EtOH (0.5 mL). The resultant suspension was stirred at r.t.
for 24 h. After completion of the reaction, most of the solvent was re-
moved under reduced pressure. H2O (5 mL), 10% aq NaOH (5 mL), and
Et2O (5 mL) were added. The organic layer was separated and the
aqueous phase was further extracted with Et2O (3 × 10 mL). The com-
bined organic layers were then washed with H2O (2 × 10 mL), brine
(15 mL), and dried (Na2SO4). The solvent was evaporated giving the
crude product, which was analyzed by 13C NMR spectroscopy to mea-
sure the diastereomeric ratio. The crude product was obtained with a
dr of 10:1. Purification was performed on a silica gel column affording
the pure product 5b (65% yield, 45% ee). Analyses were in accordance
with those obtained when the reaction was performed with 4 Å MS.
Analyses were identical to the ones obtained for the racemic product.
HPLC: (S,S)-Whelk-O1, hexane–i-PrOH + Et3N (98:2), 25 °C, 0.5
mL/min, ǽ = 230 nm, tR (major) = 8.28 min, tR (minor) = 9.23 min.
Ethyl 4-(Allylamino)-3-methyl-8-oxobicyclo[3.2.1]octane-1-car-
boxylate (9)
A 25 mL two-necked flask filled with argon was equipped a magnetic
stirrer bar. Toluene (5 mL) was then added followed by organocatalyst
V (13.2 mg, 0.032 mmol, 10 mol%). Then, ethyl 2-oxocyclopentan-
ecarboxylate (6a; 50 mg, 46.3 ǾL, 0.32 mmol, 1.0 equiv) was added
followed by methacrolein (8a; 31.2 ǾL, 0.38 mmol, 1.2 equiv), and al-
lylamine (7e; 24.0 ǾL, 0.32 mmol, 1.0 equiv). After complete conver-
sion of 6a, checked by TLC (eluent: PE–EtOAc–Et3N, 3:1:0.025), the
solution was filtered through a short pad of Celite, which was thor-
oughly washed with toluene. The solvent was evaporated under re-
duced pressure to obtain crude compound, which was analyzed by 13C
NMR spectroscopy to measure the diastereomeric ratio. The crude
product was obtained with a dr of 6:1. Purification was performed on
a silica gel column affording the pure product 9 (60% yield, 6% ee). The
racemate was prepared following the same procedure using racemic
organocatalyst V; Rf = 0.65 (PE–EtOAc–Et3N, 3:1:0.025; detection:
KMnO4).
HPLC: Chiralpak AD-H, hexane–EtOH (95:5), 25 °C, 1 mL/min, ǽ = 220
nm, tR (major) = 6.80 min, tR (minor) = 8.31 min.
1H NMR (400 MHz, CDCl3): Ƕ = 5.79 (dddd, J = 16.9, 10.2, 6.5, 5.6 Hz, 1
H), 5.11 (ddd, J = 17.2, 3.2, 1.6 Hz, 1 H), 5.01 (ddd, J = 10.2, 2.9, 1.5 Hz,
1 H), 4.23–4.05 (m, 2 H), 3.39 (ddt, J = 14.1, 5.5, 1.5 Hz, 1 H), 3.15–3.05
(m, 1 H), 2.94 (td, J = 4.5, 2.0 Hz, 1 H), 2.59–2.45 (m, 2 H), 2.36–2.22
(m, 1 H), 2.16 (td, J = 13.1, 1.3 Hz, 1 H), 2.00 (dddd, J = 15.1, 13.1, 9.0,
4.5 Hz, 2 H), 1.85 (ddd, J = 13.1, 4.9, 2.0 Hz, 1 H), 1.74–1.62 (m, 1 H),
1.22 (t, J = 7.1 Hz, 3 H), 0.96 (d, J = 6.6 Hz, 3 H).
13C NMR (101 MHz, CDCl3): Ƕ = 212.5 (C), 171.3 (C), 137.1 (CH), 116.0
(CH2), 67.1 (CH), 61.1 (CH2), 57.0 (C), 50.0 (CH2), 48.6 (CH), 42.0 (CH2),
28.5 (CH), 27.0 (CH2), 20.2 (CH2), 16.3 (CH3), 14.2 (CH3).
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